We are live on ! Find out more
AMPE

Ampio Pharmaceuticals Inc.

Delisted

AMPE was delisted on the 12th of April, 2024.

26 hedge funds and large institutions have $8.44K invested in Ampio Pharmaceuticals Inc. in 2023 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 12 increasing their positions, 4 reducing their positions, and 12 closing their positions.

New
Increased
Maintained
Reduced
Closed

200% more repeat investments, than reductions

Existing positions increased: 12 | Existing positions reduced: 4

24% less funds holding

Funds holding: 3426 (-8)

67% less first-time investments, than exits

New positions opened: 4 | Existing positions closed: 12

91% less capital invested

Capital invested by funds: $98.8K → $8.44K (-$90.4K)

Holders
26
Holders Change
-8
Holders Change %
-23.53%
% of All Funds
0.41%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
4
Increased
12
Reduced
4
Closed
12
Calls
$1.1M
Puts
Net Calls
+$1.1M
Net Calls Change
+$1.03M

AMPE Hedge Fund Activity: Q3 2023 in Review

26 of the 6,301 institutional investors tracked by Wall St. Rank reported a position in Ampio Pharmaceuticals Inc. (AMPE) for Q3 2023, worth a combined $8.44K — down 91% from $98.8K a quarter earlier.

Sellers outnumbered buyers: 12 funds closed out of AMPE and 4 opened new positions — a net loss of 8 holders — while 4 trimmed existing stakes and 12 added.

The largest buyer was Sunbelt Securities, adding an estimated $606. The largest seller was HRT Financial, exiting entirely with an estimated $24K sold.

  • 26 institutional investors held Ampio Pharmaceuticals Inc. (AMPE) as of Q3 2023, down from 34 in Q2 2023.
  • Funds reported $8.44K of Ampio Pharmaceuticals Inc. stock for Q3 2023, down 91% quarter-over-quarter.
  • 4 funds opened new Ampio Pharmaceuticals Inc. positions in Q3 2023 and 12 closed out, a net change of -8 holders.
  • The largest Ampio Pharmaceuticals Inc. buyer in Q3 2023 was Sunbelt Securities, an estimated $606 added.
  • The largest Ampio Pharmaceuticals Inc. seller in Q3 2023 was HRT Financial, an estimated $24K sold.

Based on aggregated 13F filings for Q3 2023.